ArticleJournal of microbiology & biology education2025
An interdisciplinary approach in teaching RNA secondary structure prediction to first-year undergraduate students using an automated deep learning RNA 3D model prediction tool.
Article in Journal of microbiology & biology education, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Engaging students in an AI-driven RNA drug design research project through a crowd science-infused learning approach.Journal of microbiology & biology education · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The use of artificial intelligence (AI) in biologics drug design is interlaced into the fabric of the drug discovery pipeline for many in the biotechnology industry. The use of AI tools in RNA therapeutic drug design has gained traction in recent years to develop more effective therapeutics in a short period of time, revolutionizing rapid-response therapeutics. Indeed, machine learning (ML) and deep learning (DL) are streamlining RNA therapeutic design in ways we never thought were possible just a decade ago. These advances are accompanied by a plethora of new AI tools for drug design that continue to barrage the research space at unprecedented speed. As biology educators, we bear the responsibility for keeping up with technological advances in the biotechnology space, as it is up to us to prepare and equip the next generation of scientists with the use of AI platforms in this space. Small interfering RNA (siRNA) therapeutic design remains a complex challenge, despite several of them being currently in clinical use for various genetic diseases. The application of AI and ML models can predict potent and longer-lasting siRNA drug candidates for therapeutic development. Additionally, it is imperative that siRNA candidates are screened for their propensity to form secondary structures, as this can reduce targeting efficacy and result in unwanted immune responses. Though siRNA technology is commonly taught at the undergraduate level across life sciences disciplines, there remains a disconnect between the use of AI and siRNA design in the teaching curriculum. We previously described an innovative approach for teaching students the use of a generative AI tool called Biomod AI to design siRNAs. Here, we designed an inquiry-based non-wet-lab workshop for students to explore the use of an automated DL-based RNA 3D structure prediction tool called trRosettaRNA to determine the secondary structures of siRNAs. Importantly, the interdisciplinary design of this activity amalgamates both AI and RNA science concepts in a simplified format in a single workshop tailored for first-year health sciences undergraduate students.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.